Cite
HARVARD Citation
Stepanova, M. et al. (2014). Patients' preferences and health utility assessment with SF‐6D and EQ‐5D in patients with chronic hepatitis C treated with sofosbuvir regimens. Alimentary pharmacology & therapeutics. 40 (6), pp. 676-685. [Online].